Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Oxybate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 01, 2020
Lead Product(s) : Sodium Oxybate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : GET-73
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II
Sponsor : Latis
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 01, 2018
Lead Product(s) : GET-73
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Sponsor : Latis
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : GET-73
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase I/ Phase II
Sponsor : Voisin Consulting | Latis | Quotient Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 29, 2013
Lead Product(s) : GET-73
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I/ Phase II
Sponsor : Voisin Consulting | Latis | Quotient Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable